Evidence map›Paper›PMID 33616160›Full record

ArticlePain medicine (Malden, Mass.)2021

"We Need to Taper." Interviews with Clinicians and Pharmacists About Use of a Pharmacy-Led Opioid Tapering Program.

Alison J Firemark, Jennifer L Schneider, Jennifer L Kuntz, Dea Papajorgji-Taylor, John F Dickerson, Lou Ann Thorsness, Katherine R Reese, Mark D Sullivan, Lynn L Debar, David H Smith

Open access · bronzeAbstract read
In one paragraph

Article in Pain medicine (Malden, Mass.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Alison J FiremarkKaiser Permanente Northwest Center for Health Research, Portland, Oregon, USA.ORCID 0000-0001-6767-6943
Jennifer L SchneiderKaiser Permanente Northwest Center for Health Research, Portland, Oregon, USA.
Jennifer L KuntzKaiser Permanente Northwest Center for Health Research, Portland, Oregon, USA.
Dea Papajorgji-TaylorKaiser Permanente Northwest Center for Health Research, Portland, Oregon, USA.
John F DickersonKaiser Permanente Northwest Center for Health Research, Portland, Oregon, USA.
Lou Ann ThorsnessKaiser Permanente Northwest Clinical Pharmacy Services, Portland, Oregon, USA.
Katherine R ReeseKaiser Permanente Northwest Clinical Pharmacy Services, Portland, Oregon, USA.
Mark D SullivanPsychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, USA.
Lynn L DebarKaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
David H SmithKaiser Permanente Northwest Center for Health Research, Portland, Oregon, USA.
Kaiser Permanente Center for Health Research · USKaiser Permanente · USKaiser Permanente Washington Health Research Institute · USUniversity of Washington · US

Funding

Facilitating Lower Opioid Amounts Through TaperingR01DA042124 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI SMITH, DAVID H · 2017 to 2019
$1.3M
NIDA NIH HHS R01 DA042124
6 · The paper itself

Abstract

objectiveTo identify factors that influence or interfere with referrals by primary care providers (PCPs) to a pharmacist-led telephone-based program to assist patients undergoing opioid tapering. The Support Team Onsite Resource for Management of Pain (STORM) program provides individualized patient care and supports PCPs in managing opioid tapers.

designQualitative interviews were conducted with referring PCPs and STORM staff. Interview guides addressed concepts from the RE-AIM framework, focusing on issues affecting referral to the STORM program.

settingAn integrated healthcare system (HCS) in the Northwest United States. SUBJECTS: Thirty-five interviews were conducted with 20 PCPs and 15 STORM staff.

methodsConstant comparative analysis was used to identify key themes from interviews. A codebook was developed based on interview data and a qualitative software program was used for coding, iterative review, and content analysis. Representative quotes illustrate identified themes.

resultsUse of the STORM opioid tapering program was influenced by PCP, patient, and HCS considerations. Factors motivating use of STORM included lack of PCP time to support chronic pain patients requiring opioid tapering and the perception that STORM is a valued partner in patient care. Impediments to referral included PCP confidence in managing opioid tapering, patient resistance to tapering, forgetting about program availability, and PCP resistance to evolving guidelines regarding opioid tapering goals.

conclusionsPCPs recognized that STORM supported patient safety and reduced clinician burden. Utilization of the program could be improved through ongoing PCP education about the service and consistent co-location of STORM pharmacists within primary care clinics.

Indexed as

Analgesics, OpioidPharmacyHumansNorthwestern United StatesPharmacistsPrimary Health CareAnalgesics, OpioidChronic PainOpioid TaperingPharmacyQualitativeReferral

Identifiers

PMID33616160
PMCPMC8139822
OpenAlexW3133061033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.